Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs

Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs
LONDON, UK June 2017: Visiongain’s new report Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs indicates that the global ophthalmic drugs market will see $28.1bn in spending in 2021. The global ophthalmic drugs market is expected to grow at a CAGR of 4.0% in ...

The Global Syringes Market Forecast 2017-2027: Revenue Prospects by Syringe Type, Product Type, End User and Geography

The Global Syringes Market Forecast 2017-2027: Revenue Prospects by Syringe Type, Product Type, End User and Geography
LONDON, UK. 12th June 2017: Visiongain’s new report Global Syringes Market Forecast 2017-2027: Revenue Prospects by Syringe Type (Reusable, Disposable), Material (Glass, Plastic), Product Type (Insulin, Tuberculin, Allergy, Other), End User (Hospitals, Homecare, Other) and Geography indicates that the Global Syringes market will see over $15bn in revenue in 2017. The lead analyst of the ...

The Global Anti-Inflammatory Therapeutics Market Forecast 2017-2027: Revenue Prospects by Indication, Drug Class and Geography

The Global Anti-Inflammatory Therapeutics Market Forecast 2017-2027: Revenue Prospects by Indication, Drug Class and Geography
LONDON, UK. 9th June 2017: Visiongain’s new report Global Anti-Inflammatory Therapeutics Market Forecast 2017-2027: Revenue Prospects by Indication (Arthritis, Respiratory, MS, Psoriasis, IBD, Other), Drug Class (Corticosteroids, Anti-Inflammatory Biologics, NSAIDs, Other) and Geography indicates that the Anti-Inflammatory Therapeutics market will see over $75bn in revenue in 2017. The lead analyst of the report said: “The ...

Global Next-Generation Antibody Therapies Market Forecast 2017-2027: Antibody-Drug Conjugates, Biosimilar Antibodies, Engineered Antibodies, Bispecific Antibodies, Antibody Fragments and Antibody-Like Proteins

Global Next-Generation Antibody Therapies Market Forecast 2017-2027: Antibody-Drug Conjugates, Biosimilar Antibodies, Engineered Antibodies, Bispecific Antibodies, Antibody Fragments and Antibody-Like Proteins
LONDON, UK May 2017: Visiongain’s new report Global Next-Generation Antibody Therapies Market Forecast 2017-2027: Antibody-Drug Conjugates (ADC), Biosimilar Antibodies, Engineered Antibodies, Bispecific Antibodies, Antibody Fragments and Antibody-Like Proteins (ALPs) indicates that the global next-generation antibody therapies market will see $14.1bn in spending in 2021. The global next-generation antibody therapies market is expected to grow at ...

Global Biosimilar Monoclonal Antibodies Forecast 2017-2027: Biosimilar Versions of Infliximab, Rituximab, Trastuzumab, Adalimumab, Bevacizumab and Abciximab

Global Biosimilar Monoclonal Antibodies Forecast 2017-2027: Biosimilar Versions of Infliximab, Rituximab, Trastuzumab, Adalimumab, Bevacizumab and Abciximab
LONDON, UK May 2017: Visiongain’s new report Global Biosimilar Monoclonal Antibodies Forecast 2017-2027: Biosimilar Versions of Infliximab, Rituximab, Trastuzumab, Adalimumab, Bevacizumab and Abciximab indicates that the global biosimilar monoclonal antibodies market will see $4.2bn in spending in 2020. The global biosimilar monoclonal antibodies market is expected to grow at a CAGR of 9.6% in the ...

The Systemic Lupus Erythematosus Market Forecast 2017-2027: Revenue Prospects by Product, Molecule Type, Pharmacological Class and Geography

The Systemic Lupus Erythematosus Market Forecast 2017-2027: Revenue Prospects by Product, Molecule Type, Pharmacological Class and Geography
LONDON, UK. 8th May 2017: Visiongain’s new report The Systemic Lupus Erythematosus (SLE) Market Forecast 2017-2027: Revenue Prospects by Product, Molecule Type (Small Molecules, mAbs, Recombinant Proteins), Pharmacological Class (B-Cell Targeting, Interferon Receptor Antagonists, CD Antagonists, Other) and Geography indicates that the SLE market will see over $570m in revenue in 2017. The lead analyst ...

Global Biosimilars and Follow-On Biologics Market 2017-2027: Monoclonal Antibodies, Fusion Proteins, Insulin, Erythropoietins, Granulocyte Colony-Stimulating Factor, Interferons, Growth Hormones, Fertility Hormones

Global Biosimilars and Follow-On Biologics Market 2017-2027: Monoclonal Antibodies, Fusion Proteins, Insulin, Erythropoietins, Granulocyte Colony-Stimulating Factor, Interferons, Growth Hormones, Fertility Hormones
LONDON, UK May 2017: Visiongain’s new report Global Biosimilars and Follow-On Biologics Market 2017-2027: Monoclonal Antibodies (mAbs), Fusion Proteins, Insulin, Erythropoietins, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Growth Hormones, Fertility Hormones indicates that the global biosimilars and follow-on biologics market will see $21.6bn in spending in 2021. The global biosimilars and follow-on biologics market is expected ...

Macular Degeneration and Other Retinal Diseases: World Drug Industry and Market 2016-2026

Macular Degeneration and Other Retinal Diseases: World Drug Industry and Market 2016-2026
Retinal disease pharmaceutical sales will reach $17.38bn in 2020, a new visiongain study predicts A new report by visiongain forecasts the overall world market for treating age-related macular degeneration (AMD or ARMD), diabetic retinopathy (DR) and other disorders of the retina will reach $17.38bn in 2020. That revenue forecast and others appear in Macular Degeneration ...

Global Erythropoietin Market Forecast 2017-2027: Epoetin Alfa, Epoetin Beta, Darbepoetin Alfa, Biosimilars, EPO API Manufacturing

Global Erythropoietin Market Forecast 2017-2027: Epoetin Alfa, Epoetin Beta, Darbepoetin Alfa, Biosimilars, EPO API Manufacturing
LONDON, UK April 2017: Visiongain’s new report Global Erythropoietin Market Forecast 2017-2027: Epoetin Alfa, Epoetin Beta, Darbepoetin Alfa, Biosimilars, EPO API Manufacturing indicates that the global erythropoietin market will see $11bn in spending in 2021. The global erythropoietin market is expected to grow at a CAGR of 7.8% in the first half of the forecast ...

3D Printing for Healthcare World Market 2017-2027: Forecasts By Products, By Technology & Analysis of Opportunities in Personalised Medicine, Medical Devices, Tailor Made Prosthetics, Orthopaedic Implants & Drugs

3D Printing for Healthcare World Market 2017-2027: Forecasts By Products, By Technology & Analysis of Opportunities in Personalised Medicine, Medical Devices, Tailor Made Prosthetics, Orthopaedic Implants & Drugs
LONDON, UK. 26th April 2017: Visiongain’s new report the 3D Printing for Healthcare World Market 2017-2027: Forecasts By Products (Dental Products, Medical Implants, Bio-Printing, Others) By Technology (Hardware, Software, Services) & Analysis of Opportunities in Personalised Medicine, Medical Devices, Tailor Made Prosthetics, Orthopaedic Implants & Drugs indicates that the global 3D Printing for Healthcare market will ...